Table 2 Comparison of baseline demographic, clinical, and radiological characteristics between patients with and without good outcome

Demographics

Mean age, year (SD)

58.10 (13.03)

63.38 (13.71)

 < 0.001

Sex, male, n(%)

174 (69.32)

84 (66.67)

0.601

Medical history

 Alcohol consumption, n (%)

100 (39.84)

40 (31.75)

0.124

 Smoking, n (%)

122 (48.61)

57 (45.24)

0.537

 History of Hypertension, n (%)

181 (72.11)

102 (80.96)

0.061

 History of diabetes, n (%)

30 (11.95)

29 (23.02)

0.005

 Previous ischemic stroke, n (%)

15 (5.98)

13 (10.32)

0.129

 Previous hemorrhagic stroke, n (%)

13 (5.18)

18 (14.29)

0.003

Clinical features

 Admission SBP, mmHg (SD)

181.07 (21.08)

188.74 (26.15)

0.002

 Median admission GCS score (IQR)

14 (13–15)

11 (7–14)

 < 0.001

 Median admission NIHSS score (IQR)

8 (4–12)

17 (12–26)

 < 0.001

 Median hematoma volume, ml (IQR)

9.43 (4.78–17.50)

17.59 (9.51–32.33)

 < 0.001

 Hematoma expansion, n (%)

32 (12.75)

39 (30.95)

 < 0.001

 Median time from onset to imaging, h (IQR)

2.18 (1.27–3.55)

2.00 (1.00–3.18)

0.174

 Median time from onset to treatment, h (IQR)

6.08 (3.52–25.40)

5.68 (3.27–32.75)

0.840

 Early BP reduction within 12 h, n (%)

142 (56.57)

60 (47.62)

0.100

 IVH at baseline CT, n (%)

55 (21.91)

74 (58.73)

 < 0.001

 Deep location, n (%)

191 (76.10)

100 (79.37)

0.516

Laboratory values

 White blood cell count, 10⁹/L(IQR)

9.35 (7.25–11.90)

10.47 (8.08–13.04)

0.001

 Hemoglobin, g/dL(IQR)

142.0 (134.0–156.0)

141.5 (130.0–149.3)

0.061

 Platelets,10⁹/L(IQR)

183.0 (147.5–222.5)

173.0 (133.0–208.0)

0.160

 Serum creatinine,μmol/L(IQR)

68.0 (56.0–80.8)

72.0 (60.0–90.0)

0.015

 Blood glucose level, mmol/L

6.7 (5.6–7.9)

8.1 (6.3–11.2)

 < 0.001